Expertise in
6
conditions

Christian Schoergenhofer

Vienna, AT 
Expertise in
6
conditions
Vienna, AT 

Overview

Christian Schoergenhofer practices practicing medicine in Vienna, Austria.

Mr. Schoergenhofer is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Autoimmune Hemolytic Anemia, Sepsis, Cardiac Arrest, Disseminated Intravascular Coagulation, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 148 peer reviewed articles and participating in 6 clinical trials.

Gender

Male

Locations

Vienna, Austria
Other Locations
Meidling, Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Safety, Tolerability and Efficacy of Monoclonal CD38 Antibody Felzartamab in Late Antibody-Mediated Renal Allograft Rejection - A Phase 2 Pilot Trial
Safety, Tolerability and Efficacy of Monoclonal CD38 Antibody Felzartamab in Late Antibody-Mediated Renal Allograft Rejection - A Phase 2 Pilot Trial
Enrollment Status: Completed
Publish Date: April 18, 2024
Intervention Type: Drug
Study Phase: Phase 2
Double Blinded, Randomized, Placebo Controlled, Dose Finding Trial to Evaluate the Optimal Dose of MV-ZIKA, a New Vaccine Against Zika Virus, in Regard to Immunogenicity, Safety, and Tolerability in Healthy Volunteers
Double Blinded, Randomized, Placebo Controlled, Dose Finding Trial to Evaluate the Optimal Dose of MV-ZIKA, a New Vaccine Against Zika Virus, in Regard to Immunogenicity, Safety, and Tolerability in Healthy Volunteers
Enrollment Status: Completed
Publish Date: August 18, 2022
Intervention Type: Biological, Other
Study Phase: Phase 1
A Prospective Randomized, Double Blind Study on Safety and Efficacy of Alprostadil as Additional Anticoagulant in Patients With Veno- Venous Extracorporeal Membrane Oxygenation (ECMO)
A Prospective Randomized, Double Blind Study on Safety and Efficacy of Alprostadil as Additional Anticoagulant in Patients With Veno- Venous Extracorporeal Membrane Oxygenation (ECMO)
Enrollment Status: Terminated
Publish Date: February 09, 2022
Intervention Type: Drug
Study Phase: Phase 2
Double Blinded, Randomized, Priorix®- and Placebo-controlled, Trial to Evaluate the Optimal Dose of MV-CHIK Vaccine (Against Chikungunya Virus) in Regard to Immunogenicity, Safety and Tolerability in Healthy Volunteers
Double Blinded, Randomized, Priorix®- and Placebo-controlled, Trial to Evaluate the Optimal Dose of MV-CHIK Vaccine (Against Chikungunya Virus) in Regard to Immunogenicity, Safety and Tolerability in Healthy Volunteers
Enrollment Status: Completed
Publish Date: October 29, 2021
Intervention Type: Biological
Study Phase: Phase 2
Vorapaxar in the Human Endotoxemia Model A Randomized, Double-Blind, Crossover Study
Vorapaxar in the Human Endotoxemia Model A Randomized, Double-Blind, Crossover Study
Enrollment Status: Completed
Publish Date: January 10, 2020
Intervention Type: Drug, Other
Study Phase: Phase 4
Defibrotide in the Human Endotoxemia Model -- an Exploratory Trial Investigating the Effects and the Mechanisms of Defibrotide
Defibrotide in the Human Endotoxemia Model -- an Exploratory Trial Investigating the Effects and the Mechanisms of Defibrotide
Enrollment Status: Completed
Publish Date: December 19, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 5 Less Clinical Trials

148 Total Publications

Neostigmine in Septic Shock-A Story Too Good to Be True?
Neostigmine in Septic Shock-A Story Too Good to Be True?
Journal: Critical care medicine
Published: August 06, 2026

Frequently Asked Questions about Christian Schoergenhofer

Is Christian Schoergenhofer a top-rated expert for Autoimmune Hemolytic Anemia?

MediFind is an objective health platform that identifies experts based on real-world data. Christian Schoergenhofer is classified as an Distinguished expert for Autoimmune Hemolytic Anemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Christian Schoergenhofer participate in research or clinical trials?

Yes. Christian Schoergenhofer has published 148 articles and abstracts on conditions like Autoimmune Hemolytic Anemia. You can view a list of Christian Schoergenhofer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Schoergenhofer's expertise for a condition
ConditionClose
    View All 23 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile